Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Toplak, H; Ludvik, B; Lechleitner, M; Dieplinger, H; Föger, B; Paulweber, B; Weber, T; Watschinger, B; Horn, S; Wascher, TC; Drexel, H; Brodmann, M; Pilger, E; Rosenkranz, A; Pohanka, E; Oberbauer, R; Traindl, O; Roithinger, FX; Metzler, B; Haring, HP; Kiechl, S.
Austrian Lipid Consensus on the management of metabolic lipid disorders to prevent vascular complications: A joint position statement issued by eight medical societies. 2016 update.
Wien Klin Wochenschr. 2016; 128 Suppl 2(5):S216-S228
Doi: 10.1007/s00508-016-0993-x
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Toplak Hermann
- Co-authors Med Uni Graz
- Brodmann Marianne
- Horn Sabine
- Pilger Ernst
- Rosenkranz Alexander
- Wascher Thomas
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- In 2010, eight Austrian medical societies proposed a joint position statement on the management of metabolic lipid disorders for the prevention of vascular complications. An updated and extended version of these recommendations according to the current literature is presented, referring to the primary and secondary prevention of vascular complications in adults, taking into consideration the guidelines of other societies. The "Austrian Lipid Consensus - 2016 update" provides guidance for individualized risk stratification and respective therapeutic targets, and discusses the evidence for reducing vascular endpoints with available lipid-lowering therapies. Furthermore, specific management in key patient groups is outlined, including subjects presenting with coronary, cerebrovascular, and/or peripheral atherosclerosis; diabetes mellitus and/or metabolic syndrome; nephropathy; and familial hypercholesterolemia.
- Find related publications in this database (using NLM MeSH Indexing)
- Austria -
- Cardiology - standards
- Evidence-Based Medicine -
- Humans -
- Hypolipidemic Agents - administration & dosage
- Lipid Metabolism Disorders - complications
- Lipid Metabolism Disorders - diagnosis
- Lipid Metabolism Disorders - therapy
- Practice Guidelines as Topic -
- Treatment Outcome -
- Vascular Diseases - diagnosis
- Vascular Diseases - etiology
- Vascular Diseases - prevention & control
- Find related publications in this database (Keywords)
- LDL cholesterol
- Vascular disease
- Atherosclerosis
- Primary prevention
- Secondary prevention
- Statin